两种常用非创方法在肝纤维化诊断中的作用与局限性

肝脏 ›› 2018, Vol. 23 ›› Issue (5): 381-384.

两种常用非创方法在肝纤维化诊断中的作用与局限性

陈洋溢, 吕靖, 刘成海, 赵志敏, 陈高峰

201203 上海中医药大学附属曙光医院肝硬化科(陈洋溢,吕靖,刘成海,赵志敏,陈高峰);上海市中医临床重点实验室(吕靖,刘成海)

收稿日期:2018-01-11 发布日期:2020-04-28
通讯作者: 刘成海,Email:chenghailiu@hotmail.com

Roles and limitations of two common non-invasive methods in diagnosis of liver fibrosis

CHEN Yang-yi, LV Jing, LIU Cheng-hai, ZHAO Zhi-min, CHEN Gao-feng

Department of Cirrhosis, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203;
Shanghai Key Lab of Liver Diseases of TCM, Shanghai 201203, China

Received:2018-01-11 Published:2020-04-28
Contact: LIU Cheng-hai, Email: chenghailiu@hotmail.com

摘要/Abstract

摘要： 目的统计分析腹部二维超声与FibroTouch对肝纤维化的诊断价值以及局限不足,以便更好地指导临床。方法记录相应病例的肝脏硬度值(liver stiffness measurement,LSM)及超声二维图像半定量化评分。以病理为金标准,通过受试者工作特征曲线(receptor operating characteristic curve,ROC)分析超声与FibroTouch在肝纤维化诊断中的价值,并对两种方法在肝硬化阶段的误诊病例进行比较分析。结果超声对明显纤维化期(S≥2)、进展期肝纤维化(S≥3)、早期肝硬化(S=4)诊断的曲线下面积(area under the curve,AUC)分别为0.915、0.873、0.821;FibroTouch检查分别为0.854、0.802、0.727。超声组有87例(34%),FibroTouch组有45例(27%)出现诊断结果偏倚。结论超声与FibroTouch是两种可靠的超声肝纤维化无创诊断方法,可以作为一种行之有效的替代方法,用于疾病诊断、疗效观察。

关键词: 肝纤维化, 超声, FibroTouch, 非创诊断方法

Abstract: Objective To investigate the value and limitation of abdominal ultrasonography (AUS) and FibroTouch (FT) in the diagnosis of liver fibrosis for better clinical application. Methods Liver stiffness measurement and semi-quantitative AUS score were recorded. Diagnostic value of AUS and FT for liver fibrosis was assessed with receiver operating characteristic curve using liver biopsy as the gold standard. Moreover, cases misdiagnosed of cirrhosis by the two methods were comparatively analyzed. Results The areas under the curve of AUS and FT for apparent fibrosis (S≥2), progressive fibrosis (S≥3) and early cirrhosis (S=4) were 0.915, 0.873, 0.821 and 0.854, 0.802, 0.727, respectively. There were 87 cases (34%) in AUS group and 45 cases (27%) in FT group with biased diagnosis. Conclusion AUS and FT may serve as two reliable ultrasonic non-invasive methods for the diagnosis of liver fibrosis, which can be applied for observation of clinical efficacy. However, liver biopsy and non-invasive methods should be used under comprehensive analysis because of their disadvantages.

Key words: Hepatic Fibrosis, Ultrasonography, FibroTouch, Non-invasive diagnosis

陈洋溢, 吕靖, 刘成海, 赵志敏, 陈高峰. 两种常用非创方法在肝纤维化诊断中的作用与局限性[J]. 肝脏, 2018, 23(5): 381-384.

CHEN Yang-yi, LV Jing, LIU Cheng-hai, ZHAO Zhi-min, CHEN Gao-feng. Roles and limitations of two common non-invasive methods in diagnosis of liver fibrosis[J]. Chinese Hepatolgy, 2018, 23(5): 381-384.

参考文献

[1] Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem,2000,275: 2247-2250.
[2] Liaw YF. Reversal of cirrhosis:an achievable goal of hepatitis B antiviral therapy.J Hepatol, 2013,59: 880-881.
[3] Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy.Hepatology, 2009,49: 1017-1044.
[4] Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.World J Gastroenterol,2014,20: 475-485.
[5] European Association for Study of Liver,Association Latinoamericana para el Estudio del Hiqado.EASL-ALEH clinical practice guidelines:Non-invasive tests for evaluation of liver disease severity and prognosis.J Hepatol, 2015,63:237-264.
[6] Shiha G,Ibrahim A, Helmy A, et al. Asian-Pacific Association for the Study of the Liver(APASL)consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis:a 2016 update.Hepatol Int,2017,11: 1-30.
[7] Lim JK, Flamm SL, Singh S, et al.American gastroenterological association institute guideline on the role of elastography in the evaluation of liver fibrosis.J Gastroenterol, 2017,152:1536-1543.
[8] 曾民德,王泰龄,王宝恩. 肝纤维化诊断和疗效评估共识.诊断学理论与实践,2002, 3: 67-68.
[9] 孟繁坤,丁蕾,曲锰, 等. 高频超声观察肝实质形态的改变对慢性肝病肝纤维化分期的价值.中国医学影像技,2006,22:916-918.
[10] Marcellin P,Ziol M,Bedossa P,et al.Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B.Liver Int,2009,29: 242-247.
[11] 吴娜,张明媛,吴瑞红,等.Fibro Scan与Fibro Touch对肝纤维化程度诊断价值的比较分析.临床肝胆病杂志,2014,30: 624-627.
[12] Liang XE,Chen YP,Zhang Q,et al. Dynamic evaluation of liver stiffness measurement to improve diagnostic accuracy of liver cirrhosis in patients with chronic hepatitis B acute exacerbation.Viral Hepatol,2011,18:884-891.
[13] Wong GL,Wong VW,Choi PC,et al. Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B.Gastroenterol Hepatol,2009,24: 1002-1007.
[14] Millonig G,Reimann FM,Friedrich S,et al. Extrahepatic cholestasis increases liver stiffness(Fibro Scan)irrespective of fibrosis.Hepatology,2008,48: 1718-1723.

[1]	程静, 徐路, 彭素琼. 肝血流超声参数联合外周血vWF-Ag对肝硬化患者食管静脉曲张出血的预测价值[J]. 肝脏, 2020, 25(3): 260-263.
[2]	冯俊, 常凤玲. 超声造影LI-RADS分类标准在肝细胞癌鉴别及诊断中的应用[J]. 肝脏, 2020, 25(3): 297-299.
[3]	李友学. 三维超声造影对肝癌消融治疗后残留病灶的诊断价值[J]. 肝脏, 2020, 25(2): 175-180.
[4]	李松, 张娟. 替诺福韦酯对乙型肝炎肝硬化患者肝纤维化状态与Th1/Th2型细胞因子的影响研究[J]. 肝脏, 2020, 25(1): 54-55.
[5]	马春明, 张锁才, 史罗明, 吴剑明, 周根法, 郑剑. 慢性乙型肝炎外周血浆样树突状细胞与免疫应答的关系及干预分析[J]. 肝脏, 2020, 25(1): 34-35.
[6]	刘薇, 袁海霞, 时强. 抗病毒治疗慢性乙型肝炎肝硬化后肝纤维化逆转情况观察[J]. 肝脏, 2019, 24(9): 1055-1057.
[7]	周晓颖, 王琳, 崔祖丽. Fibroscan对乙型肝炎并发酒精性肝病患者肝脏纤维化的诊断效果[J]. 肝脏, 2019, 24(9): 1058-1060.
[8]	刘琴, 时建国. MANF蛋白对乙型肝炎患者肝脏纤维化程度的诊断效果分析[J]. 肝脏, 2019, 24(9): 1063-1065.
[9]	钱嵘, 杨唯衷. 经颅多普勒超声结合屏气试验评价肝硬化患者大脑中动脉血流动力学改变[J]. 肝脏, 2019, 24(8): 861-863.
[10]	陆伟, 刘丹萍, 张占卿, 王雁冰, 丁荣蓉, 周新兰, 黄丹, 李秀芬, 杨可芷. APRI、GPR和FIB-4预测抗病毒诱导的乙型肝炎肝硬化肝脏病理学回归的性能评价[J]. 肝脏, 2019, 24(8): 875-882.
[11]	严华. 超声造影在诊断肝脏转移性神经内分泌肿瘤中的价值[J]. 肝脏, 2019, 24(8): 902-904.
[12]	武永萍, 魏占芳, 石栓柱, 马莉莎, 朱悦. 瞬时弹性超声成像在评价乙型肝炎肝纤维化严重程度中的价值[J]. 肝脏, 2019, 24(8): 905-907.
[13]	韩玥, 刘春波, 陈小雅, 吴长君. 超声造影定量分析在肝脏肿瘤诊断中的应用及其临床价值[J]. 肝脏, 2019, 24(8): 924-926.
[14]	高峻, 郭旭升, 韩利杰. 血清ASMase水平对非酒精性脂肪性肝病患者肝纤维化程度的预测价值[J]. 肝脏, 2019, 24(8): 926-928.
[15]	周学刚, 蔡兴文. 非神经内分泌来源转移性肝癌患者超声造影特点分析[J]. 肝脏, 2019, 24(8): 932-933.